| Year |
Citation |
Score |
| 2024 |
Edwards DM, Schonewolf CA, Rice JD, Schipper M, Haken RKT, Matuszak M, Balter J, Jarema D, Arenberg DA, Piert M, Qin A, Kalemkerian GP, Schneider BJ, Ramnath N, Chapman CH, et al. Phase II Trial Assessing Toxicity of Personalized Response-Based Radiation Treatment in Patients with Locally Advanced Non-Small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics. PMID 38971385 DOI: 10.1016/j.ijrobp.2024.06.018 |
0.338 |
|
| 2022 |
Mierzwa ML, Aryal M, Lee C, Schipper M, VanTil M, Rivera KM, Swiecicki PL, Casper KA, Malloy KM, Spector ME, Shuman AG, Chinn SB, Prince MEP, Stucken CL, Rosko AJ, et al. Randomized Phase II study of Physiologic MRI-directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 36107219 DOI: 10.1158/1078-0432.CCR-22-1522 |
0.305 |
|
| 2022 |
Polan DF, Epelman MA, Wu VW, Sun Y, Varsta M, Owen DR, Jarema D, Matrosic CK, Jolly S, Schonewolf CA, Schipper MJ, Matuszak MM. Direct incorporation of patient-specific efficacy and toxicity estimates in radiation therapy plan optimization. Medical Physics. PMID 35994026 DOI: 10.1002/mp.15940 |
0.308 |
|
| 2022 |
Hinton T, Karnak D, Tang M, Jiang R, Luo Y, Boonstra P, Sun Y, Nancarrow DJ, Sandford E, Ray P, Maurino C, Matuszak M, Schipper MJ, Green MD, Yanik GA, et al. Improved prediction of radiation pneumonitis by combining biological and radiobiological parameters using a data-driven Bayesian network analysis. Translational Oncology. 21: 101428. PMID 35460942 DOI: 10.1016/j.tranon.2022.101428 |
0.618 |
|
| 2022 |
Li P, Taylor JMG, Boonstra PS, Lawrence TS, Schipper MJ. Utility based approach in individualized optimal dose selection using machine learning methods. Statistics in Medicine. PMID 35343595 DOI: 10.1002/sim.9396 |
0.627 |
|
| 2022 |
Laucis AMB, Hochstedler KA, Schipper MJ, Paximadis PA, Boike TP, Bergsma DP, Movsas B, Kretzler A, Spratt DE, Dess RT, Mietzel MA, Dominello MM, Matuszak MM, Jagsi R, Hayman JA, et al. Racial Differences in Treatments and Toxicity in Patients With Non-Small-Cell Lung Cancer Treated With Thoracic Radiation Therapy. Jco Oncology Practice. OP2100224. PMID 35167337 DOI: 10.1200/OP.21.00224 |
0.31 |
|
| 2022 |
Herr DJ, Hochstedler KA, Yin H, Dess RT, Matuszak M, Grubb M, Dominello M, Movsas B, Kestin LL, Bergsma D, Dragovic AF, Grills IS, Hayman JA, Paximadis P, Schipper M, et al. Effect of Education and Standardization of Cardiac Dose Constraints on Heart Dose in Patients With Lung Cancer Receiving Definitive Radiation Therapy Across a Statewide Consortium. Practical Radiation Oncology. PMID 35121192 DOI: 10.1016/j.prro.2022.01.002 |
0.315 |
|
| 2021 |
Owen DR, Sun Y, Boonstra PS, McFarlane M, Viglianti BL, Balter JM, El Naqa I, Schipper MJ, Schonewolf CA, Ten Haken RK, Kong FS, Jolly S, Matuszak MM. Investigating the SPECT Dose-Function Metrics Associated With Radiation-Induced Lung Toxicity Risk in Patients With Non-small Cell Lung Cancer Undergoing Radiation Therapy. Advances in Radiation Oncology. 6: 100666. PMID 33817412 DOI: 10.1016/j.adro.2021.100666 |
0.654 |
|
| 2020 |
Jackson WC, Tang M, Maurino C, Mendiratta-Lala M, Parikh ND, Matuszak MM, Dow JS, Cao Y, Mayo CS, Ten Haken RK, Schipper MJ, Cuneo KC, Owen D, Lawrence TS. Individualized adaptive radiation therapy allows for safe treatment of hepatocellular carcinoma in patients with Child-Turcotte-Pugh B liver disease. International Journal of Radiation Oncology, Biology, Physics. PMID 32853708 DOI: 10.1016/J.Ijrobp.2020.08.046 |
0.343 |
|
| 2020 |
Jackson WC, Hartman HE, Dess RT, Birer SR, Soni PD, Hearn JWD, Reichert ZR, Kishan AU, Mahal BA, Zumsteg ZS, Efstathiou JA, Kaffenberger S, Morgan TM, Mehra R, Showalter TN, ... ... Schipper MJ, et al. Addition of Androgen-Deprivation Therapy or Brachytherapy Boost to External Beam Radiotherapy for Localized Prostate Cancer: A Network Meta-Analysis of Randomized Trials. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1903217. PMID 32396488 DOI: 10.1200/Jco.19.03217 |
0.34 |
|
| 2020 |
Wilkie JR, Mierzwa ML, Casper KA, Mayo CS, Schipper MJ, Eisbruch A, Worden FP, El Naqa I, Viglianti BL, Rosen BS. Predicting late radiation-induced xerostomia with parotid gland PET biomarkers and dose metrics. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 148: 30-37. PMID 32311598 DOI: 10.1016/J.Radonc.2020.03.037 |
0.373 |
|
| 2020 |
Mendiratta-Lala M, Masch W, Owen D, Aslam A, Maurino C, Devasia T, Schipper MJ, Parikh ND, Cuneo K, Lawrence TS, Davenport MS. Natural history of hepatocellular carcinoma after stereotactic body radiation therapy. Abdominal Radiology (New York). PMID 32303772 DOI: 10.1007/S00261-020-02532-4 |
0.329 |
|
| 2020 |
Dess RT, Sun Y, Jackson WC, Jairath NK, Kishan AU, Wallington DG, Mahal BA, Stish BJ, Zumsteg ZS, Den RB, Hall WA, Gharzai LA, Jaworski EM, Reichert ZR, Morgan TM, ... ... Schipper MJ, et al. Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer. Jama Oncology. PMID 32215583 DOI: 10.1001/Jamaoncol.2020.0109 |
0.345 |
|
| 2020 |
Kim MM, Parmar HA, Schipper M, Devasia T, Aryal MP, Kesari S, O'Day S, Morikawa A, Spratt DE, Junck L, Mammoser A, Hayman JA, Lawrence TS, Tsien CI, Aiken R, et al. BRAINSTORM: A Multi-Institutional Phase I/II Study of RRx-001 in Combination with Whole Brain Radiation Therapy for Patients with Brain Metastases. International Journal of Radiation Oncology, Biology, Physics. PMID 32169409 DOI: 10.1016/J.Ijrobp.2020.02.639 |
0.315 |
|
| 2020 |
Spratt DE, Malone S, Roy S, Grimes S, Eapen L, Morgan SC, Malone J, Craig J, Dess RT, Jackson W, Schipper MJ, Michalski JM, Lee WR, Pisansky TM, Feng FY, et al. Short-term adjuvant versus neoadjuvant hormone therapy in localized prostate cancer: A pooled individual patient analysis of two phase III trials. Journal of Clinical Oncology. 38: 5584-5584. DOI: 10.1200/Jco.2020.38.15_Suppl.5584 |
0.345 |
|
| 2020 |
Gharzai L, Li P, Jaworski E, Schipper M, Burger N, Wilkie J, Chapman C, Schonewolf C, Casper K, Mierzwa M. Can patient reported quality of life predict locoregional recurrence in oropharyngeal cancer? International Journal of Radiation Oncology*Biology*Physics. 106: 1199-1200. DOI: 10.1016/J.Ijrobp.2019.11.050 |
0.304 |
|
| 2019 |
Cao Y, Aryal M, Li P, Lee C, Schipper M, Hawkins PG, Chapman C, Owen D, Dragovic AF, Swiecicki P, Casper K, Worden F, Lawrence TS, Eisbruch A, Mierzwa M. Predictive Values of MRI and PET Derived Quantitative Parameters for Patterns of Failure in Both p16+ and p16- High Risk Head and Neck Cancer. Frontiers in Oncology. 9: 1118. PMID 31799173 DOI: 10.3389/Fonc.2019.01118 |
0.353 |
|
| 2019 |
Li P, Taylor JMG, Kong S, Jolly S, Schipper MJ. A utility approach to individualized optimal dose selection using biomarkers. Biometrical Journal. Biometrische Zeitschrift. PMID 31692022 DOI: 10.1002/Bimj.201900030 |
0.44 |
|
| 2019 |
Jackson WC, Suresh K, Maurino C, Feng M, Cuneo KC, Ten Haken RK, Lawrence TS, Schipper MJ, Owen D. A mid-treatment break and reassessment maintains tumor control and reduces toxicity in patients with hepatocellular carcinoma treated with stereotactic body radiation therapy. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 31431377 DOI: 10.1016/J.Radonc.2019.07.027 |
0.38 |
|
| 2019 |
Cuneo KC, Morgan MA, Sahai V, Schipper MJ, Parsels LA, Parsels JD, Devasia T, Al-Hawaray M, Cho CS, Nathan H, Maybaum J, Zalupski MM, Lawrence TS. Dose Escalation Trial of the Wee1 Inhibitor Adavosertib (AZD1775) in Combination With Gemcitabine and Radiation for Patients With Locally Advanced Pancreatic Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1900730. PMID 31398082 DOI: 10.1200/Jco.19.00730 |
0.412 |
|
| 2019 |
Dess RT, Sun Y, Muenz DG, Paximadis PA, Dominello MM, Grills IS, Kestin LL, Movsas B, Masi KJ, Matuszak MM, Radawski JD, Moran JM, Pierce LJ, Hayman JA, Schipper MJ, et al. Cardiac Dose in Locally Advanced Lung Cancer: Results from a Statewide Consortium. Practical Radiation Oncology. PMID 31382026 DOI: 10.1016/J.Prro.2019.07.013 |
0.423 |
|
| 2019 |
Dewaraja YK, Devasia T, Kaza RK, Mikell JK, Owen D, Roberson PL, Schipper M. Prediction of tumor control in Y radioembolization by logit models with PET/CT based dose metrics. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 31147404 DOI: 10.2967/Jnumed.119.226472 |
0.392 |
|
| 2019 |
Cuneo KC, Devasia T, Sun Y, Schipper MJ, Karnak D, Davis MA, Owen D, Feng M, El Naqa I, Bazzi L, Ten Haken R, Lawrence TS. Serum Levels of Hepatocyte Growth Factor and CD40 Ligand Predict Radiation-Induced Liver Injury. Translational Oncology. 12: 889-894. PMID 31078059 DOI: 10.1016/J.Tranon.2019.04.003 |
0.317 |
|
| 2019 |
Kim MM, Speers C, Li P, Schipper M, Junck L, Leung D, Orringer D, Heth J, Umemura Y, Spratt DE, Wahl DR, Cao Y, Lawrence TS, Tsien CI. Dose-intensified chemoradiation is associated with altered patterns of failure and favorable survival in patients with newly diagnosed glioblastoma. Journal of Neuro-Oncology. PMID 30977058 DOI: 10.1007/S11060-019-03166-3 |
0.344 |
|
| 2019 |
Hawkins PG, Sun Y, Dess RT, Jackson WC, Sun G, Bi N, Tewari M, Hayman JA, Kalemkerian GP, Gadgeel SM, Lawrence TS, Haken RKT, Matuszak MM, Kong FS, Schipper MJ, et al. Circulating microRNAs as biomarkers of radiation-induced cardiac toxicity in non-small-cell lung cancer. Journal of Cancer Research and Clinical Oncology. PMID 30923943 DOI: 10.1007/S00432-019-02903-5 |
0.398 |
|
| 2019 |
Cuneo KC, Morgan MA, Zalupski MM, Sahai V, Schipper MJ, Maybaum J, Lawrence TS. Abstract CT235: A dose escalation trial of the Wee1 inhibitor AZD1775, in combination with gemcitabine and radiation for patients with locally advanced pancreatic cancer Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-Ct235 |
0.475 |
|
| 2019 |
Kim M, Aryal M, Parmar H, Li P, Schipper M, Wahl D, Lawrence T, Cao Y. NIMG-77. RESPONSE ASSESSMENT USING MULTIPARAMETRIC MRI DURING CHEMORADIATION PREDICTS OVERALL SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA Neuro-Oncology. 21: vi179-vi179. DOI: 10.1093/Neuonc/Noz175.746 |
0.336 |
|
| 2019 |
Dess R, Sun Y, Matuszak M, Sun G, Schonewolf C, Kong F, Gadgeel S, Kalemkerian G, Hayman J, Haken RKT, Lawrence T, Schipper M, Jolly S. Interplay of Cardiac and Pulmonary Toxicity: An Analysis of Prospective Trials for Locally Advanced Non-Small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 105: E504. DOI: 10.1016/J.Ijrobp.2019.06.1323 |
0.34 |
|
| 2018 |
Jackson WC, Suresh K, Tumati V, Dess RT, Soni PD, Zhao SG, Zumsteg ZS, Hannan R, Hollenbeck BK, George A, Kaffenberger SD, Salami SS, Hearn JWD, Morgan TM, Mehra R, ... Schipper M, et al. Impact of Biochemical Failure After Salvage Radiation Therapy on Prostate Cancer-specific Mortality: Competition Between Age and Time to Biochemical Failure. European Urology Oncology. 1: 276-282. PMID 31100248 DOI: 10.1016/J.Euo.2018.04.014 |
0.335 |
|
| 2018 |
McCulloch MM, Muenz DG, Schipper MJ, Velec M, Dawson LA, Brock KK. A simulation study to assess the potential impact of developing normal tissue complication probability models with accumulated dose. Advances in Radiation Oncology. 3: 662-672. PMID 30370368 DOI: 10.1016/J.Adro.2018.05.003 |
0.316 |
|
| 2018 |
Hawkins PG, Tang M, Vineberg KA, Young L, Kovach K, Lee C, Maturen KE, Uppal S, Owen D, Schipper MJ, Prisciandaro JI, Jolly S. Dosimetric impact of interfractional organs at risk variation during high-dose rate interstitial brachytherapy for gynecologic malignancies. Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists. PMID 30336971 DOI: 10.1016/J.Meddos.2018.09.001 |
0.399 |
|
| 2018 |
Mendiratta-Lala M, Masch W, Shankar PR, Hartman HE, Davenport MS, Schipper MJ, Maurino C, Cuneo KC, Lawrence TS, Owen D. MR Imaging Evaluation of Hepatocellular Carcinoma Treated with Stereotactic Body Radiation Therapy (SBRT): Long Term Imaging Follow-Up. International Journal of Radiation Oncology, Biology, Physics. PMID 30213751 DOI: 10.1016/J.Ijrobp.2018.09.004 |
0.338 |
|
| 2018 |
Owen DR, Boonstra PS, Viglianti BL, Balter JM, Schipper MJ, Jackson WC, El Naqa I, Jolly S, Ten Haken RK, Kong FS, Matuszak MM. Modeling Patient-Specific Dose-Function Response for Enhanced Characterization of Personalized Functional Damage. International Journal of Radiation Oncology, Biology, Physics. PMID 30108006 DOI: 10.1016/J.Ijrobp.2018.05.049 |
0.427 |
|
| 2018 |
Wahl DR, Kim MM, Aryal MP, Hartman H, Lawrence TS, Schipper MJ, Parmar HA, Cao Y. Combining Perfusion and High B-value Diffusion MRI to Inform Prognosis and Predict Failure Patterns in Glioblastoma. International Journal of Radiation Oncology, Biology, Physics. PMID 29980414 DOI: 10.1016/J.Ijrobp.2018.04.045 |
0.318 |
|
| 2018 |
Dess RT, Devasia TP, Aghdam N, Jackson WC, Soni PD, Smith CP, Mitchell AL, Suy S, Hamstra DA, Jolly S, Nguyen PL, Feng FY, Schipper MJ, Skolarus TA, Miller DC, et al. Patient-Reported Sexual Aid Utilization and Efficacy After Radiation Therapy for Localized Prostate Cancer. International Journal of Radiation Oncology, Biology, Physics. PMID 29487023 DOI: 10.1016/J.Ijrobp.2018.01.055 |
0.328 |
|
| 2018 |
Jackson WC, Tao Y, Mendiratta-Lala M, Bazzi L, Wahl DR, Schipper MJ, Feng M, Cuneo KC, Lawrence TS, Owen D. Comparison of Stereotactic Body Radiation Therapy and Radiofrequency Ablation in the Treatment of Intrahepatic Metastases. International Journal of Radiation Oncology, Biology, Physics. 100: 950-958. PMID 29485074 DOI: 10.1016/J.Ijrobp.2017.12.014 |
0.366 |
|
| 2018 |
Jackson WC, Suresh K, Tumati V, Allen SG, Dess RT, Salami SS, George A, Kaffenberger SD, Miller DC, Hearn JWD, Jolly S, Mehra R, Hollenbeck BK, Palapattu GS, Schipper M, et al. Intermediate Endpoints After Postprostatectomy Radiotherapy: 5-Year Distant Metastasis to Predict Overall Survival. European Urology. PMID 29306514 DOI: 10.1016/j.eururo.2017.12.023 |
0.354 |
|
| 2018 |
Jackson WC, Dess RT, Litzenberg DW, Li P, Schipper M, Rosenthal SA, Chang GC, Horwitz EM, Price RA, Michalski JM, Gay HA, Wei JT, Feng M, Feng FY, Sandler HM, et al. A multi-institutional phase 2 trial of prostate stereotactic body radiation therapy (SBRT) using continuous real-time evaluation of prostate motion with patient-reported quality of life. Practical Radiation Oncology. 8: 40-47. PMID 29304991 DOI: 10.1016/J.Prro.2017.08.004 |
0.355 |
|
| 2018 |
Kim M, Parmar H, Aryal M, Schipper M, Devasia T, Kesari S, Morikawa A, Spratt D, Junck L, Hayman J, Lawrence T, Tsien C, Aiken R, Goyal S, Knox S, et al. CMET-46. INITIAL CLINICAL AND ADVANCED IMAGING OUTCOMES FROM A MULTI-INSTITUTIONAL PHASE I DOSE-ESCALATION TRIAL OF RRX-001 PLUS WHOLE BRAIN RADIATION FOR PATIENTS WITH BRAIN METASTASES Neuro-Oncology. 20: vi63-vi63. DOI: 10.1093/Neuonc/Noy148.255 |
0.365 |
|
| 2017 |
Hawkins PG, Boonstra PS, Hobson ST, Hayman JA, Ten Haken RK, Matuszak MM, Stanton P, Kalemkerian GP, Lawrence TS, Schipper MJ, Kong FS, Jolly S. Prediction of Radiation Esophagitis in Non-Small Cell Lung Cancer Using Clinical Factors, Dosimetric Parameters, and Pretreatment Cytokine Levels. Translational Oncology. 11: 102-108. PMID 29220828 DOI: 10.1016/J.Tranon.2017.11.005 |
0.684 |
|
| 2017 |
Masi K, Archer P, Jackson W, Sun Y, Schipper M, Hamstra D, Matuszak M. Knowledge-based treatment planning and its potential role in the transition between treatment planning systems. Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists. 43: 251-257. PMID 29174796 DOI: 10.1016/J.Meddos.2017.10.001 |
0.31 |
|
| 2017 |
Suresh K, Owen D, Bazzi L, Jackson W, Ten Haken RK, Cuneo K, Feng M, Lawrence TS, Schipper MJ. Using Indocyanine Green Extraction to Predict Liver Function After Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma. International Journal of Radiation Oncology, Biology, Physics. PMID 29128147 DOI: 10.1016/J.Ijrobp.2017.09.032 |
0.315 |
|
| 2017 |
Roberson PL, Smith LB, Morgan MA, Schipper MJ, Wilderman SJ, Avram AM, Kaminski MS, Dewaraja YK. Beyond Dose: Using Pretherapy Biomarkers to Improve Dose Prediction of Outcomes for Radioimmunotherapy of Non-Hodgkin Lymphoma. Cancer Biotherapy & Radiopharmaceuticals. PMID 29083933 DOI: 10.1089/Cbr.2017.2182 |
0.395 |
|
| 2017 |
Sapir E, Tao Y, Schipper MJ, Bazzi L, Novelli PM, Devlin P, Owen D, Cuneo KC, Lawrence TS, Parikh ND, Feng M. Stereotactic Body Radiation Therapy as an Alternative to Transarterial Chemoembolization for Hepatocellular Carcinoma. International Journal of Radiation Oncology, Biology, Physics. PMID 29066120 DOI: 10.1016/J.Ijrobp.2017.09.001 |
0.344 |
|
| 2017 |
Sun Y, Hawkins PG, Bi N, Dess RT, Tewari M, Hearn JWD, Hayman JA, Kalemkerian GP, Lawrence TS, Ten Haken RK, Matuszak MM, Kong FM, Jolly S, Schipper MJ. Serum MicroRNA Signature Predicts Response to High-Dose Radiation Therapy in Locally Advanced Non-Small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics. PMID 29051037 DOI: 10.1016/J.Ijrobp.2017.08.039 |
0.43 |
|
| 2017 |
Hawkins PG, Boonstra PS, Hobson ST, Hearn JWD, Hayman JA, Ten Haken RK, Matuszak MM, Stanton P, Kalemkerian GP, Ramnath N, Lawrence TS, Schipper MJ, Spring Kong FM, Jolly S. Radiation-induced lung toxicity in non-small-cell lung cancer: Understanding the interactions of clinical factors and cytokines with the dose-toxicity relationship. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 28947099 DOI: 10.1016/J.Radonc.2017.09.005 |
0.664 |
|
| 2017 |
Paximadis P, Schipper M, Matuszak M, Feng M, Jolly S, Boike T, Grills I, Kestin L, Movsas B, Griffith K, Gustafson G, Moran J, Nurushev T, Radawski J, Pierce L, et al. Dosimetric predictors for acute esophagitis during radiation therapy for lung cancer: Results of a large statewide observational study. Practical Radiation Oncology. PMID 28919249 DOI: 10.1016/J.Prro.2017.07.010 |
0.416 |
|
| 2017 |
Hawkins PG, Lee JY, Mao Y, Li P, Green M, Worden FP, Swiecicki PL, Mierzwa ML, Spector ME, Schipper MJ, Eisbruch A. Sparing all salivary glands with IMRT for head and neck cancer: Longitudinal study of patient-reported xerostomia and head-and-neck quality of life. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 28823405 DOI: 10.1016/J.Radonc.2017.08.002 |
0.34 |
|
| 2017 |
Dess RT, Hartman HE, Aghdam N, Jackson WC, Soni PD, Abugharib AE, Suy S, Desai NB, Zumsteg ZS, Mehra R, Morgan TM, Feng FY, Hamstra DA, Schipper MJ, Collins SP, et al. Erectile Function after Stereotactic Body Radiotherapy for Localized Prostate Cancer. Bju International. PMID 28710895 DOI: 10.1111/Bju.13962 |
0.321 |
|
| 2017 |
Kong FM, Ten Haken RK, Schipper M, Frey KA, Hayman J, Gross M, Ramnath N, Hassan KA, Matuszak M, Ritter T, Bi N, Wang W, Orringer M, Cease KB, Lawrence TS, et al. Effect of Midtreatment PET/CT-Adapted Radiation Therapy With Concurrent Chemotherapy in Patients With Locally Advanced Non-Small-Cell Lung Cancer: A Phase 2 Clinical Trial. Jama Oncology. PMID 28570742 DOI: 10.1001/Jamaoncol.2017.0982 |
0.404 |
|
| 2017 |
Foy JJ, Marsh R, Ten Haken RK, Younge KC, Schipper M, Sun Y, Owen D, Matuszak MM. An analysis of knowledge-based planning for stereotactic body radiation therapy of the spine. Practical Radiation Oncology. PMID 28433524 DOI: 10.1016/J.Prro.2017.02.007 |
0.32 |
|
| 2017 |
Dess RT, Sun Y, Matuszak MM, Sun G, Soni PD, Bazzi L, Murthy VL, Hearn JW, Kong FM, Kalemkerian GP, Hayman JA, Ten Haken RK, Lawrence TS, Schipper MJ, Jolly S. Cardiac Events After Radiation Therapy: Combined Analysis of Prospective Multicenter Trials for Locally Advanced Non-Small-Cell Lung Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016716142. PMID 28301264 DOI: 10.1200/Jco.2016.71.6142 |
0.37 |
|
| 2017 |
Spratt DE, Lee JY, Dess RT, Narayana V, Evans C, Liss A, Winfield R, Schipper MJ, Lawrence TS, McLaughlin PW. Vessel-sparing Radiotherapy for Localized Prostate Cancer to Preserve Erectile Function: A Single-arm Phase 2 Trial. European Urology. PMID 28233591 DOI: 10.1016/J.Eururo.2017.02.007 |
0.313 |
|
| 2017 |
Cuneo KC, Morgan M, Schipper MJ, Maybaum J, Al-Hawary M, Simeone DM, Sahai V, Zalupski M, Lawrence TS. Phase I study of definitive chemoradiation with gemcitabine and the WEE1 inhibitor AZD1775 in unresectable pancreatic cancer. Journal of Clinical Oncology. 35. DOI: 10.1200/Jco.2017.35.4_Suppl.Tps512 |
0.385 |
|
| 2016 |
Soni PD, Boonstra PS, Schipper MJ, Bazzi L, Dess RT, Matuszak MM, Kong FM, Hayman JA, Ten Haken RK, Lawrence TS, Kalemkerian GP, Jolly S. Lower Incidence of Esophagitis in the Elderly Undergoing Definitive Radiation Therapy for Lung Cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 28161553 DOI: 10.1016/J.Ijrobp.2017.01.191 |
0.674 |
|
| 2016 |
Hawkins PG, Boonstra PS, Ten Haken RK, Matuszak MM, Kong FS, Lawrence TS, Schipper MJ, Jolly S. MINI01.13: Prediction of Lung Toxicity in the Definitive Radiotherapy of Non-Small Cell Lung Cancer using Clinical, Dosimetric and Biologic Factors: Topic: Radiation Oncology. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 11: S264-S265. PMID 27969461 DOI: 10.1016/J.Jtho.2016.09.028 |
0.66 |
|
| 2016 |
Lee JY, Suresh K, Nguyen R, Sapir E, Dow JS, Arnould GS, Worden FP, Spector ME, Prince ME, McLean SA, Shuman AG, Malloy KM, Casper K, Bradford CR, Schipper MJ, et al. Predictors of severe long-term toxicity after re-irradiation for head and neck cancer. Oral Oncology. 60: 32-40. PMID 27531870 DOI: 10.1016/J.Oraloncology.2016.06.017 |
0.328 |
|
| 2016 |
Sapir E, Tao Y, Feng F, Samuels S, El Naqa I, Murdoch-Kinch CA, Feng M, Schipper M, Eisbruch A. Predictors of Dysgeusia in Patients With Oropharyngeal Cancer Treated With Chemotherapy and Intensity Modulated Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. PMID 27473816 DOI: 10.1016/J.Ijrobp.2016.05.011 |
0.409 |
|
| 2016 |
Jackson WC, Schipper MJ, Feng FY. Reply to Yu-Wen Hu's Letter to the Editor re: William C. Jackson, Matthew J. Schipper, Skyler B. Johnson, et al. Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy. Eur Urol 2016;69:50-7. European Urology. PMID 27210457 DOI: 10.1016/J.Eururo.2016.04.039 |
0.326 |
|
| 2016 |
Kim MM, Parmar H, Cao Y, Pramanik P, Schipper M, Hayman J, Junck L, Mammoser A, Heth J, Carter CA, Oronsky A, Knox SJ, Caroen S, Oronsky B, Scicinski J, et al. Whole Brain Radiotherapy and RRx-001: Two Partial Responses in Radioresistant Melanoma Brain Metastases from a Phase I/II Clinical Trial: A TITE-CRM Phase I/II Clinical Trial. Translational Oncology. 9: 108-13. PMID 27084426 DOI: 10.1016/J.Tranon.2015.12.003 |
0.313 |
|
| 2016 |
Shilkrut M, Sapir E, Hanasoge S, Schipper MJ, Normolle DP, Ben-Josef E, Ensminger W, Lawrence TS, Feng M. Phase I Trial of Dose-escalated Whole Liver Irradiation With Hepatic Arterial Fluorodeoxyuridine/Leucovorin and Streptozotocin Followed by Fluorodeoxyuridine/Leucovorin and Chemoembolization for Patients With Neuroendocrine Hepatic Metastases. American Journal of Clinical Oncology. PMID 26886946 DOI: 10.1097/Coc.0000000000000276 |
0.386 |
|
| 2016 |
Kim MM, Camelo-Piragua S, Schipper M, Tao Y, Normolle D, Junck L, Mammoser A, Betz BL, Cao Y, Kim CJ, Heth J, Sagher O, Lawrence TS, Tsien CI. Gemcitabine Plus Radiation Therapy for High-Grade Glioma: Long-Term Results of a Phase 1 Dose-Escalation Study. International Journal of Radiation Oncology, Biology, Physics. 94: 305-11. PMID 26853339 DOI: 10.1016/J.Ijrobp.2015.10.032 |
0.416 |
|
| 2016 |
Samuels SE, Tao Y, Lyden T, Haxer M, Spector M, Malloy KM, Prince ME, Bradford CR, Worden FP, Schipper M, Eisbruch A. Comparisons of dysphagia and quality of life (QOL) in comparable patients with HPV-positive oropharyngeal cancer receiving chemo-irradiation or cetuximab-irradiation. Oral Oncology. PMID 26776757 DOI: 10.1016/J.Oraloncology.2015.12.001 |
0.336 |
|
| 2016 |
Feng MU, Suresh K, Schipper MJ, Bazzi L, Ben-Josef E, Matuszak M, Parikh N, Welling TH, Ten Haken RK, Lawrence TS. Phase II study of individualized adaptive stereotactic body radiotherapy (SBRT) for patients at high risk for liver damage. Journal of Clinical Oncology. 34: 424-424. DOI: 10.1200/Jco.2016.34.4_Suppl.424 |
0.393 |
|
| 2016 |
Cuneo KC, Sun Y, Schipper MJ, Tewari M, Lawrence TS, Feng MU. The use of plasma microRNAs to predict toxicty following liver stereotactic body radiation therapy. Journal of Clinical Oncology. 34: 245-245. DOI: 10.1200/Jco.2016.34.4_Suppl.245 |
0.366 |
|
| 2016 |
Swiecicki P, Schipper MJ, Malloy KM, Stucken C, Shuman AG, Spector ME, Chepeha DB, Casper K, McLean SA, Moyer J, Wolf GT, Prince ME, Bradford CR, Carey TE, Eisbruch A, et al. Phase II prospective trial of cetuximab and radiotherapy for locally advanced, squamous cell carcinomas of the head and neck in patients >70 years old or with comorbidities not-eligible for platinum-based chemotherapy. Journal of Clinical Oncology. 34: 6071-6071. DOI: 10.1200/Jco.2016.34.15_Suppl.6071 |
0.353 |
|
| 2016 |
Cuneo KC, Morgan M, Schipper MJ, Maybaum J, Feng MU, Al-Hawary M, Simeone DM, Olson LD, Sahai V, Zalupski M, Lawrence TS. Abstract CT035: A dose escalation trial of the WEE1 inhibitor AZD1775, gemcitabine, and concurrent radiation in locally advanced pancreatic cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Ct035 |
0.462 |
|
| 2015 |
Matuszak MM, Hadley SW, Feng M, Hayman JA, Brock KK, Burger P, Owen D, Suresh K, Schipper M, Lawrence TS, Moran JM. Enhancing safety and quality through preplanning peer review for patients undergoing stereotactic body radiation therapy. Practical Radiation Oncology. PMID 26746815 DOI: 10.1016/J.Prro.2015.09.009 |
0.365 |
|
| 2015 |
Vainshtein JM, Samuels S, Tao Y, Lyden T, Haxer M, Spector M, Schipper M, Eisbruch A. Impact of xerostomia on dysphagia after chemotherapy-intensity-modulated radiotherapy for oropharyngeal cancer: Prospective longitudinal study. Head & Neck. PMID 26605872 DOI: 10.1002/Hed.24286 |
0.363 |
|
| 2015 |
Zhou J, Fang CX, Shen J, Schipper MJ, Zalupski MM, Minter RM, Simeone DM, Hart D, Eagle T, Kimmel GW, Vainshtein J, Lawrence TS, Feng M. Definitive Chemoradiation With Full-dose Gemcitabine for Unresectable Pancreatic Cancer: Efficacy of Involved-Field Radiotherapy. American Journal of Clinical Oncology. PMID 26165418 DOI: 10.1097/Coc.0000000000000200 |
0.398 |
|
| 2015 |
Jackson WC, Schipper MJ, Johnson SB, Foster C, Li D, Sandler HM, Palapattu GS, Hamstra DA, Feng FY. Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy. European Urology. PMID 26004800 DOI: 10.1016/J.Ijrobp.2013.06.405 |
0.355 |
|
| 2015 |
Boonstra PS, Shen J, Taylor JM, Braun TM, Griffith KA, Daignault S, Kalemkerian GP, Lawrence TS, Schipper MJ. A statistical evaluation of dose expansion cohorts in phase I clinical trials. Journal of the National Cancer Institute. 107. PMID 25710960 DOI: 10.1093/Jnci/Dju429 |
0.652 |
|
| 2015 |
Feng FY, Zhao S, Prensner J, Erho N, Schipper MJ, Shi Y, Magi-Galluzzi C, Siddiqui J, Davicioni E, Den RB, Dicker A, Karnes RJ, Wei JT, Klein EA, Jenkins RB, et al. Investigating the long noncoding RNA SChLAP1 as a prognostic tissue and urine biomarker in prostate cancer. Journal of Clinical Oncology. 33: 7-7. DOI: 10.1200/Jco.2015.33.7_Suppl.7 |
0.326 |
|
| 2015 |
Lu L, Tao Y, Schipper MJ, Wahl D, Stenmark MH, Lawrence TS, Feng MU. Association between equivalent uniform dose (EUD) and rates of local progression in liver tumors treated with stereotactic body radiation therapy (SBRT). Journal of Clinical Oncology. 33: 380-380. DOI: 10.1200/Jco.2015.33.3_Suppl.380 |
0.419 |
|
| 2014 |
Prensner JR, Zhao S, Erho N, Schipper M, Iyer MK, Dhanasekaran SM, Magi-Galluzzi C, Mehra R, Sahu A, Siddiqui J, Davicioni E, Den RB, Dicker AP, Karnes RJ, Wei JT, et al. RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1. The Lancet. Oncology. 15: 1469-80. PMID 25456366 DOI: 10.1016/S1470-2045(14)71113-1 |
0.307 |
|
| 2014 |
Cuneo KC, Chenevert TL, Ben-Josef E, Feng MU, Greenson JK, Hussain HK, Simeone DM, Schipper MJ, Anderson MA, Zalupski MM, Al-Hawary M, Galban CJ, Rehemtulla A, Feng FY, Lawrence TS, et al. A pilot study of diffusion-weighted MRI in patients undergoing neoadjuvant chemoradiation for pancreatic cancer. Translational Oncology. 7: 644-9. PMID 25389460 DOI: 10.1016/J.Tranon.2014.07.005 |
0.303 |
|
| 2014 |
Schipper MJ, Taylor JM, TenHaken R, Matuzak MM, Kong FM, Lawrence TS. Personalized dose selection in radiation therapy using statistical models for toxicity and efficacy with dose and biomarkers as covariates. Statistics in Medicine. 33: 5330-9. PMID 25164860 DOI: 10.1002/Sim.6285 |
0.441 |
|
| 2014 |
Zheng X, Schipper M, Kidwell K, Lin J, Reddy R, Ren Y, Chang A, Lv F, Orringer M, Spring Kong FM. Survival outcome after stereotactic body radiation therapy and surgery for stage I non-small cell lung cancer: a meta-analysis. International Journal of Radiation Oncology, Biology, Physics. 90: 603-11. PMID 25052562 DOI: 10.1016/J.Ijrobp.2014.05.055 |
0.395 |
|
| 2014 |
Dewaraja YK, Schipper MJ, Shen J, Smith LB, Murgic J, Savas H, Youssef E, Regan D, Wilderman SJ, Roberson PL, Kaminski MS, Avram AM. Tumor-Absorbed Dose Predicts Progression-Free Survival Following (131)I-Tositumomab Radioimmunotherapy. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 1047-53. PMID 24842891 DOI: 10.2967/Jnumed.113.136044 |
0.431 |
|
| 2014 |
Schipper MJ, Taylor JM, Smith GL, Jagsi R. Comparing long-term treatment-associated toxicities in cancer patients: approaches, caveats, and recommendations. International Journal of Radiation Oncology, Biology, Physics. 89: 232-4. PMID 24837886 DOI: 10.1016/J.Ijrobp.2014.01.030 |
0.385 |
|
| 2014 |
Goodsitt MM, Shenoy A, Shen J, Howard D, Schipper MJ, Wilderman S, Christodoulou E, Chun SY, Dewaraja YK. Evaluation of dual energy quantitative CT for determining the spatial distributions of red marrow and bone for dosimetry in internal emitter radiation therapy. Medical Physics. 41: 051901. PMID 24784380 DOI: 10.1118/1.4870378 |
0.305 |
|
| 2014 |
Zhou J, Prisciandaro J, Lee C, Schipper M, Eisbruch A, Jolly S. Single or multi-channel vaginal cuff high-dose-rate brachytherapy: Is replanning necessary prior to each fraction? Practical Radiation Oncology. 4: 20-6. PMID 24621419 DOI: 10.1016/J.Prro.2012.12.005 |
0.317 |
|
| 2014 |
Vainshtein JM, Schipper M, Vance S, Feng FY, Olson KB, Hamstra DA. Limitations of the Cancer of the Prostate Risk Assessment (CAPRA) Prognostic Tool for Prediction of Metastases and Prostate Cancer-specific Mortality in Patients Treated With External Beam Radiation Therapy. American Journal of Clinical Oncology. PMID 24487421 DOI: 10.1097/Coc.0000000000000037 |
0.352 |
|
| 2014 |
Roberson PL, Wilderman SJ, Avram AM, Kaminski MS, Schipper MJ, Dewaraja YK. Biological-effect modeling of radioimmunotherapy for non-hodgkins lymphoma: determination of model parameters. Cancer Biotherapy & Radiopharmaceuticals. 29: 26-33. PMID 24102174 DOI: 10.1089/Cbr.2012.1467 |
0.33 |
|
| 2014 |
Demiroz C, Vainshtein JM, Koukourakis GV, Gutfeld O, Prince ME, Bradford CR, Wolf GT, McLean S, Worden FP, Chepeha DB, Schipper MJ, McHugh JB, Eisbruch A. Head and neck squamous cell carcinoma of unknown primary: neck dissection and radiotherapy or definitive radiotherapy. Head & Neck. 36: 1589-95. PMID 23996575 DOI: 10.1002/Hed.23479 |
0.332 |
|
| 2014 |
Kim M, Schipper M, Cao Y, Junck L, Mammoser A, Heth J, Sagher O, Lawrence T, Tsien C. AT-32A PHASE I DOSE-ESCALATION STUDY OF GEMCITABINE PLUS STANDARD RADIATION THERAPY FOR MALIGNANT HIGH GRADE GLIOMAS Neuro-Oncology. 16: v15-v15. DOI: 10.1093/Neuonc/Nou237.32 |
0.402 |
|
| 2013 |
Hunter KU, Fernandes LL, Vineberg KA, McShan D, Antonuk AE, Cornwall C, Feng M, Schipper MJ, Balter JM, Eisbruch A. Parotid glands dose-effect relationships based on their actually delivered doses: implications for adaptive replanning in radiation therapy of head-and-neck cancer. International Journal of Radiation Oncology, Biology, Physics. 87: 676-82. PMID 24035328 DOI: 10.1016/J.Ijrobp.2013.07.040 |
0.311 |
|
| 2013 |
Liu E, Stenmark MH, Schipper MJ, Balter JM, Kessler ML, Caoili EM, Lee OE, Ben-Josef E, Lawrence TS, Feng M. Stereotactic body radiation therapy for primary and metastatic liver tumors. Translational Oncology. 6: 442-6. PMID 23908687 DOI: 10.1593/Tlo.12448 |
0.363 |
|
| 2013 |
Wang W, Xu Y, Schipper M, Matuszak MM, Ritter T, Cao Y, Ten Haken RK, Kong FM. Effect of normal lung definition on lung dosimetry and lung toxicity prediction in radiation therapy treatment planning. International Journal of Radiation Oncology, Biology, Physics. 86: 956-63. PMID 23845844 DOI: 10.1016/J.Ijrobp.2013.05.003 |
0.388 |
|
| 2013 |
Yuan ST, Ellingrod VL, Schipper M, Stringer KA, Cai X, Hayman JA, Yu J, Lawrence TS, Kong FM. Genetic variations in TGFβ1, tPA, and ACE and radiation-induced thoracic toxicities in patients with non-small-cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 8: 208-13. PMID 23334061 DOI: 10.1097/Jto.0B013E318274592E |
0.384 |
|
| 2013 |
Vainshtein JM, Schipper M, Zalupski MM, Lawrence TS, Abrams R, Francis IR, Khan G, Leslie W, Ben-Josef E. Prognostic significance of carbohydrate antigen 19-9 in unresectable locally advanced pancreatic cancer treated with dose-escalated intensity modulated radiation therapy and concurrent full-dose gemcitabine: analysis of a prospective phase 1/2 dose escalation study. International Journal of Radiation Oncology, Biology, Physics. 86: 96-101. PMID 23265573 DOI: 10.1016/J.Ijrobp.2012.11.020 |
0.349 |
|
| 2013 |
Hunter KU, Schipper M, Feng FY, Lyden T, Haxer M, Murdoch-Kinch CA, Cornwall B, Lee CS, Chepeha DB, Eisbruch A. Toxicities affecting quality of life after chemo-IMRT of oropharyngeal cancer: prospective study of patient-reported, observer-rated, and objective outcomes. International Journal of Radiation Oncology, Biology, Physics. 85: 935-40. PMID 23040224 DOI: 10.1016/J.Ijrobp.2012.08.030 |
0.342 |
|
| 2013 |
Zhou J, Shen J, Schipper MJ, Lawrence TS, Feng MU. Definitive chemoradiation with full-dose gemcitabine for unresectable pancreatic cancer: A single-institution experience. Journal of Clinical Oncology. 31: 331-331. DOI: 10.1200/Jco.2013.31.4_Suppl.331 |
0.387 |
|
| 2013 |
Bi N, Schipper MJ, Stanton P, Wang W, Kong F(. Serum miRNA signature to identify a patient’s resistance to high-dose radiation therapy for unresectable non-small cell lung cancer. Journal of Clinical Oncology. 31: 7580-7580. DOI: 10.1200/Jco.2013.31.15_Suppl.7580 |
0.333 |
|
| 2013 |
Kong F, Ten Haken RK, Schipper MJ, Hayman J, Ramnath N, Hassan KA, Matuszak M, Ritter T, Bi N, Wang W, Orringer M, Cease KB, Lawrence TS, Kalemkerian GP. A phase II trial of mid-treatment FDG-PET adaptive, individualized radiation therapy plus concurrent chemotherapy in patients with non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 31: 7522-7522. DOI: 10.1200/Jco.2013.31.15_Suppl.7522 |
0.454 |
|
| 2012 |
Liu E, Stenmark MH, Lee OE, Schipper MJ, Caoili EM, Ben-Josef E, Lawrence TS, Feng MU. SBRT as an alternative to RFA for the treatment of primary and metastatic liver tumors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 158. PMID 27982899 DOI: 10.1200/Jco.2012.30.4_Suppl.158 |
0.34 |
|
| 2012 |
Schipper MJ, Koral KF, Avram AM, Kaminski MS, Dewaraja YK. Prediction of therapy tumor-absorbed dose estimates in I-131 radioimmunotherapy using tracer data via a mixed-model fit to time activity. Cancer Biotherapy & Radiopharmaceuticals. 27: 403-11. PMID 22947086 DOI: 10.1089/Cbr.2011.1053 |
0.346 |
|
| 2012 |
Tsien CI, Brown D, Normolle D, Schipper M, Piert M, Junck L, Heth J, Gomez-Hassan D, Ten Haken RK, Chenevert T, Cao Y, Lawrence T. Concurrent temozolomide and dose-escalated intensity-modulated radiation therapy in newly diagnosed glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 273-9. PMID 22065084 DOI: 10.1158/1078-0432.Ccr-11-2073 |
0.419 |
|
| 2012 |
Little M, Schipper M, Feng FY, Vineberg K, Cornwall C, Murdoch-Kinch CA, Eisbruch A. Reducing xerostomia after chemo-IMRT for head-and-neck cancer: beyond sparing the parotid glands. International Journal of Radiation Oncology, Biology, Physics. 83: 1007-14. PMID 22056067 DOI: 10.1016/J.Ijrobp.2011.09.004 |
0.428 |
|
| 2012 |
Shilkrut M, Schipper MJ, Ensminger WD, Ben-Josef E, Lawrence TS, Feng MU. Phase I trial of dose escalated whole liver irradiation (WLRT) with hepatic arterial (HA) fluorodeoxyuridine (FUDR)/leucovorin (LV)/streptozotocin (STZ) chemotherapy followed by chemoembolization with mitomycin C (MMC) for patients with neuroendocrine hepatic metastases. Journal of Clinical Oncology. 30. DOI: 10.1200/Jco.2012.30.15_Suppl.E14603 |
0.362 |
|
| 2011 |
Stenmark MH, Liu E, Schipper MJ, Ben-Josef E, Lawrence TS, Feng MU. SBRT outcomes for primary and metastatic liver lesions. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 262. PMID 27985580 DOI: 10.1200/Jco.2011.29.4_Suppl.262 |
0.387 |
|
| 2011 |
Halverson S, Schipper M, Blas K, Lee V, Sabolch A, Olson K, Sandler HM, Feng FY, Hamstra DA. The Cancer of the Prostate Risk Assessment (CAPRA) in patients treated with external beam radiation therapy: evaluation and optimization in patients at higher risk of relapse. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 101: 513-20. PMID 21703711 DOI: 10.1016/J.Radonc.2011.05.080 |
0.381 |
|
| 2011 |
Roberson PL, Amro H, Wilderman SJ, Avram AM, Kaminski MS, Schipper MJ, Dewaraja YK. Bio-effect model applied to 131I radioimmunotherapy of refractory non-Hodgkin's lymphoma. European Journal of Nuclear Medicine and Molecular Imaging. 38: 874-83. PMID 21174088 DOI: 10.1007/S00259-010-1699-3 |
0.354 |
|
| 2010 |
Pai D, Willatt JM, Korobkin M, Cohan RH, Ellis JH, Francis IR, Wolf JS, Schipper M. CT appearances following laparoscopic partial nephrectomy for renal cell carcinoma using a rolled cellulose bolster. Cancer Imaging : the Official Publication of the International Cancer Imaging Society. 10: 161-8. PMID 20675248 DOI: 10.1102/1470-7330.2010.0023 |
0.306 |
|
| 2010 |
Dewaraja YK, Schipper MJ, Roberson PL, Wilderman SJ, Amro H, Regan DD, Koral KF, Kaminski MS, Avram AM. 131I-tositumomab radioimmunotherapy: initial tumor dose-response results using 3-dimensional dosimetry including radiobiologic modeling. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 1155-62. PMID 20554734 DOI: 10.2967/Jnumed.110.075176 |
0.397 |
|
| 2009 |
Caoili EM, Cohan RH, Ellis JH, Dillman J, Schipper MJ, Francis IR. Medical decision making regarding computed tomographic radiation dose and associated risk: the patient's perspective. Archives of Internal Medicine. 169: 1069-71. PMID 19506177 DOI: 10.1001/Archinternmed.2009.139 |
0.338 |
|
| 2008 |
Soto DE, Glaser S, Roberts RH, Schipper MJ, McLaughlin PW, Ray ME, Sandler HM, Pan CC. Impact of common iliac nodal treatment on radiation outcomes in localized prostate cancer. Urology. 71: 313-7. PMID 18308110 DOI: 10.1016/J.Urology.2007.08.037 |
0.395 |
|
| 2008 |
Khan MK, Minc LD, Nigavekar SS, Kariapper MS, Nair BM, Schipper M, Cook AC, Lesniak WG, Balogh LP. Fabrication of {198Au0} radioactive composite nanodevices and their use for nanobrachytherapy. Nanomedicine : Nanotechnology, Biology, and Medicine. 4: 57-69. PMID 18249156 DOI: 10.1016/J.Nano.2007.11.005 |
0.307 |
|
| 2008 |
Schipper M, Taylor JMG, Lin X. Generalized monotonic functional mixed models with application to modelling normal tissue complications Journal of the Royal Statistical Society Series C-Applied Statistics. 57: 149-163. DOI: 10.1111/J.1467-9876.2007.00606.X |
0.4 |
|
| 2007 |
Schipper M, Taylor JM, Lin X. Bayesian generalized monotonic functional mixed models for the effects of radiation dose histograms on normal tissue complications. Statistics in Medicine. 26: 4643-56. PMID 17407198 DOI: 10.1002/Sim.2887 |
0.4 |
|
| 2006 |
Khan MK, Mamou F, Schipper MJ, May KS, Kwitny A, Warnat A, Bolton B, Nair BM, Kariapper MS, Miller M, Brewer G, Normolle D, Merajver SD, Teknos TN. Combination tetrathiomolybdate and radiation therapy in a mouse model of head and neck squamous cell carcinoma. Archives of Otolaryngology--Head & Neck Surgery. 132: 333-8. PMID 16549755 DOI: 10.1001/Archotol.132.3.333 |
0.357 |
|
| 2005 |
Kong FM, Ten Haken RK, Schipper MJ, Sullivan MA, Chen M, Lopez C, Kalemkerian GP, Hayman JA. High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study. International Journal of Radiation Oncology, Biology, Physics. 63: 324-33. PMID 16168827 DOI: 10.1016/J.Ijrobp.2005.02.010 |
0.481 |
|
| 2005 |
Feng M, Jabbari S, Lin A, Bradford CR, Chepeha DB, Teknos TN, Worden FP, Tsien C, Schipper MJ, Wolf GT, Dawson LA, Eisbruch A. Predictive factors of local-regional recurrences following parotid sparing intensity modulated or 3D conformal radiotherapy for head and neck cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 77: 32-8. PMID 16154219 DOI: 10.1016/J.Radonc.2005.07.008 |
0.38 |
|
| 2005 |
Hayman JA, Kabeto MU, Schipper MJ, Bennett JE, Vicini FA, Pierce LJ. Assessing the benefit of radiation therapy after breast-conserving surgery for ductal carcinoma-in-situ. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 5171-7. PMID 16051959 DOI: 10.1200/Jco.2005.11.692 |
0.364 |
|
| 2004 |
Krueger EA, Schipper MJ, Koelling T, Marsh RB, Butler JB, Pierce LJ. Cardiac chamber and coronary artery doses associated with postmastectomy radiotherapy techniques to the chest wall and regional nodes. International Journal of Radiation Oncology, Biology, Physics. 60: 1195-203. PMID 15519792 DOI: 10.1016/J.Ijrobp.2004.04.026 |
0.305 |
|
| 2004 |
Suh WW, Schott AF, Hayman JA, Schipper MJ, Shewach DS, Pierce LJ. A phase I dose escalation trial of gemcitabine with radiotherapy for breast cancer in the treatment of unresectable chest wall recurrences. The Breast Journal. 10: 204-10. PMID 15125746 DOI: 10.1111/J.1075-122X.2004.21305.X |
0.399 |
|
| 2004 |
Dawson LA, Saito NG, Ratanatharathorn V, Uberti JP, Adams PT, Ayash LJ, Reynolds CM, Silver SM, Schipper MJ, Lichter AS, Eisbruch A. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease. International Journal of Radiation Oncology, Biology, Physics. 59: 208-18. PMID 15093918 DOI: 10.1016/J.Ijrobp.2003.07.004 |
0.394 |
|
| 2004 |
Eisbruch A, Marsh LH, Dawson LA, Bradford CR, Teknos TN, Chepeha DB, Worden FP, Urba S, Lin A, Schipper MJ, Wolf GT. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing. International Journal of Radiation Oncology, Biology, Physics. 59: 28-42. PMID 15093896 DOI: 10.1016/J.Ijrobp.2003.10.032 |
0.363 |
|
| Show low-probability matches. |